Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
نویسندگان
چکیده
1. Kitcharoen S, Pattapongsin M, Sawanyawisuth K, Angela V, Tiamkao S. Neurologic manifestations of pandemic (H1N1) 2009 virus infection. Emerg Infect Dis. 2010;16:569–70. DOI: 10.3201/ eid1603.091699 2. Kuiken T, Taubenberger JK. Pathology of human infl uenza revisited. Vaccine. 2008;26(Suppl 4):D59–66. DOI: 10.1016/j.vaccine.2008.07.025 3. Ito Y, Ichiyama T, Kimura H, Shibata M, Ishiwada N, Kuroki H, et al. Detection of infl uenza virus RNA by reverse transcription PCR and proinfl ammatory cytokines in infl uenza-virusassociated encephalopathy. J Med Virol. 1999;58:420–5. DOI: 10.1002/(SICI)1096-9071(199908) 58:4<420::AID-JMV16>3.0.CO;2-T 4. Franková V, Jirásek A, Tumová B. Type A infl uenza: postmortem virus isolations from different organs in human lethal cases. Arch Virol. 1977;53:265–8. DOI: 10.1007/BF01314671 5. Centers for Disease Control and Prevention. Neurologic complications associated with novel infl uenza A (H1N1) virus infection in children, Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:773–8. 6. Gonzalez BE, Brust DG. Novel infl uenza A (H1N1) presenting as an acute febrile encephalopathy in a mother and daughter. Clin Infect Dis. 2009;49:1966–7. DOI: 10.1086/649014 7. Webster RI, Hazelton B, Suleiman J, Macartney K, Kesson A, Dale RC. Severe encephalopathy with swine origin infl uenza A H1N1 infection in childhood: case reports. Neurology. 2010;74:1077–8. DOI: 10.1212/WNL.0b013e3181d6b113 8. Sánchez-Torrent L, Triviño-Rodriguez M, Suero-Toledano P, Claret-Teruel G, Muñoz-Almagro C, Martínez-Sánchez L, et al. Novel infl uenza A (H1N1) encephalitis in a 3-month-old infant. Infection. 2010;38:227–9. DOI: 10.1007/s15010010-0014-3 9. Amin R, Ford-Jones E, Richardson SE, MacGregor D, Tellier R, Heurter H, et al. Acute childhood encephalitis and encephalopathy associated with infl uenza: a prospective 11-year review. Pediatr Infect Dis J. 2008;27:390–5. DOI: 10.1097/ INF.0b013e31816507b2 10. Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S. Cerebrospinal fl uid and serum levels of cytokines and soluble tumor necrosis factor receptor in infl uenza virus associated encephalopathy. Scand J Infect Dis. 2003;35:59–61. DOI: 10.1080/0036554021000026986
منابع مشابه
Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
Influenza viruses resistant to antiviral drugs emerge frequently. Not surprisingly, the widespread treatment in many countries of patients infected with 2009 pandemic influenza A (H1N1) viruses with the neuraminidase (NA) inhibitors oseltamivir and zanamivir has led to the emergence of pandemic strains resistant to these drugs. Sporadic cases of pandemic influenza have been associated with muta...
متن کاملOseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico
During May 2009-April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in Mexico. We detected the H275Y substitution of the neuraminidase gene in a specimen from an infant with pandemic (H1N1) 2009 who was treated with oseltamivir. This virus was susceptible to zanamivir and resistant to adamantanes and oseltamivir.
متن کاملOseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.
After a 10-day course of oral oseltamivir for pandemic (H1N1) 2009 influenza infection, a renal transplant recipient developed rapid-onset severe primary viral pneumonia due to oseltamivir-resistant virus. Respiratory failure progressed despite high-dose oral oseltamivir, nebulised zanamivir and cessation of immunosuppressive medications, but his condition improved with intravenous zanamivir. H...
متن کاملMonitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010
To monitor and characterize oseltamivir-resistant (OR) pandemic (H1N1) 2009 virus with the H275Y mutation, we analyzed 4,307 clinical specimens from Japan by neuraminidase (NA) sequencing or inhibition assay; 61 OR pandemic (H1N1) 2009 viruses were detected. NA inhibition assay and M2 sequencing indicated that OR pandemic (H1N1) 2009 virus was resistant to M2 inhibitors, but sensitive to zanami...
متن کاملAcute Encephalopathy and Pandemic (H1N1) 2009
copy and nasal wash specimens from patient 4 also were negative for such antigens on laboratory testing. This underscores the limitations of current testing and that the sensitivity of pandemic (H1N1) 2009 diagnostic testing remains poor and needs further improvement. Thus, in patients suspected of having pandemic (H1N1) 2009 or in those who are critically ill, lower tract respiratory specimens...
متن کاملPandemic (H1N1) 2009 influenza.
On 11 June 2009, the World Health Organization declared the first human influenza pandemic since 1968–1969. The responsible virus, pandemic (H1N1) 2009 influenza, is a novel triple-reassortant influenza A virus, incorporating avian, swine and human influenza genes.1 The virus is resistant to the anti-influenza medications, amantadine and rimantadine, but is generally sensitive to the neuraminid...
متن کامل